Study of EVM14 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called EVM14, alone or with other treatments, for people with advanced solid tumors that can't be removed by surgery or have spread. It aims to see if the drug is safe and helps shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor cancer that is advanced, cannot be removed by surgery, has come back, or has spread.
- You must have at least one tumor that can be measured on a scan.
- You should be able to take care of yourself (ECOG score 0 or 1).
- Your organs (like heart, liver, kidneys) must be working well enough.
- You need to provide a sample of your tumor for testing (either from an earlier procedure or a new biopsy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new immune cell therapy (EVM16) given alone or with another drug (tislelizumab) for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination can help shrink tumors or slow their growth.
This trial tests an experimental drug (TEV‑56278) alone or with another drug (pembrolizumab) for people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it helps shrink tumors.
This trial tests a new drug (EVM14) combined with an existing immunotherapy called ivonescimab for people with advanced squamous lung cancer that has not been treated before. The goal is to see if the combination is safe and if it helps shrink tumors.
This trial tests a new study drug, GV20-0251, for people with advanced solid tumors that no longer respond to standard therapies. It aims to see if the drug can shrink tumors or slow their growth.
This Phase 1 trial tests VVD-130037, a new experimental medicine, to see if it is safe and tolerable in people with advanced (metastatic or unresectable) solid cancers. If you have already tried standard treatments and your body can handle study medication, you may be eligible—especially for certain lung, head and neck, or esophageal cancer types with specific genetic changes.
This study tests a new drug called ES014 for people with advanced solid tumors that can't be removed or have spread. It's an early trial to see if ES014 is safe and helps fight certain cancers.
Hear when a new Selected Types of Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.